These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1690316)

  • 1. Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.
    Visscher DW; Zarbo RJ; Jacobsen G; Kambouris A; Talpos G; Sakr W; Crissman JD
    Lab Invest; 1990 Mar; 62(3):370-8. PubMed ID: 1690316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
    Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
    Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry.
    Visscher DW; Sochacki P; Ottosen S; Wykes S; Crissman JD
    Anal Cell Pathol; 1995 Jun; 8(4):267-77. PubMed ID: 7577742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas.
    Visscher DW; Wykes S; Zarbo RJ; Crissman JD
    Anal Quant Cytol Histol; 1991 Aug; 13(4):246-52. PubMed ID: 1718294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated peak detection and cell cycle analysis of flow cytometric DNA histograms.
    Kallioniemi OP; Visakorpi T; Holli K; Isola JJ; Rabinovitch PS
    Cytometry; 1994 Jul; 16(3):250-5. PubMed ID: 7924694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up.
    Prasad AR; Divine G; Zarbo RJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
    Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
    Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
    Hedley DW; Rugg CA; Gelber RD
    Cancer Res; 1987 Sep; 47(17):4729-35. PubMed ID: 3621170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast.
    Frost AR; Karcher DS; Terahata S; Siegel RS; Silverberg SG
    Mod Pathol; 1996 Sep; 9(9):930-7. PubMed ID: 8878026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
    Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
    Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ
    Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
    Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
    Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
    Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
    Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle analysis of normal, atrophic, and hyperplastic breast epithelium using two-color multiparametric flow cytometry.
    Visscher DW; Gingrich DS; Buckley J; Tabaczka P; Crissman JD
    Anal Cell Pathol; 1996 Nov; 12(2):115-24. PubMed ID: 8986295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric enumeration and kinetic analysis of inflammatory cell populations in breast carcinomas.
    Visscher DW; VanBree G; Ottosen S; Wykes S; Crissman JD
    Anal Cell Pathol; 1993 Nov; 5(6):321-30. PubMed ID: 8305328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
    Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
    Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.